UniProt ID | TMOD3_HUMAN | |
---|---|---|
UniProt AC | Q9NYL9 | |
Protein Name | Tropomodulin-3 | |
Gene Name | TMOD3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 352 | |
Subcellular Localization | Cytoplasm, cytoskeleton. | |
Protein Description | Blocks the elongation and depolymerization of the actin filaments at the pointed end. The Tmod/TM complex contributes to the formation of the short actin protofilament, which in turn defines the geometry of the membrane skeleton (By similarity).. | |
Protein Sequence | MALPFRKDLEKYKDLDEDELLGNLSETELKQLETVLDDLDPENALLPAGFRQKNQTSKSTTGPFDREHLLSYLEKEALEHKDREDYVPYTGEKKGKIFIPKQKPVQTFTEEKVSLDPELEEALTSASDTELCDLAAILGMHNLITNTKFCNIMGSSNGVDQEHFSNVVKGEKILPVFDEPPNPTNVEESLKRTKENDAHLVEVNLNNIKNIPIPTLKDFAKALETNTHVKCFSLAATRSNDPVATAFAEMLKVNKTLKSLNVESNFITGVGILALIDALRDNETLAELKIDNQRQQLGTAVELEMAKMLEENTNILKFGYQFTQQGPRTRAANAITKNNDLVRKRRVEGDHQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
11 | Ubiquitination | PFRKDLEKYKDLDED CCHHCHHHCCCCCHH | 65.97 | 22817900 | |
11 | Acetylation | PFRKDLEKYKDLDED CCHHCHHHCCCCCHH | 65.97 | 26051181 | |
12 | Phosphorylation | FRKDLEKYKDLDEDE CHHCHHHCCCCCHHH | 10.60 | 30278072 | |
13 | Ubiquitination | RKDLEKYKDLDEDEL HHCHHHCCCCCHHHH | 63.98 | 21906983 | |
13 | Acetylation | RKDLEKYKDLDEDEL HHCHHHCCCCCHHHH | 63.98 | 26051181 | |
25 | Phosphorylation | DELLGNLSETELKQL HHHHCCCCHHHHHHH | 46.61 | 19664994 | |
27 | Phosphorylation | LLGNLSETELKQLET HHCCCCHHHHHHHHH | 43.15 | 29255136 | |
34 | Phosphorylation | TELKQLETVLDDLDP HHHHHHHHHHHHCCH | 34.65 | 28464451 | |
53 | Ubiquitination | LPAGFRQKNQTSKST CCCCCCCCCCCCCCC | 46.93 | 29967540 | |
58 | Ubiquitination | RQKNQTSKSTTGPFD CCCCCCCCCCCCCCC | 56.03 | 24816145 | |
59 | Phosphorylation | QKNQTSKSTTGPFDR CCCCCCCCCCCCCCH | 30.85 | 30576142 | |
60 | Phosphorylation | KNQTSKSTTGPFDRE CCCCCCCCCCCCCHH | 39.24 | 21815630 | |
61 | Phosphorylation | NQTSKSTTGPFDREH CCCCCCCCCCCCHHH | 50.37 | 28152594 | |
71 | Phosphorylation | FDREHLLSYLEKEAL CCHHHHHHHHHHHHH | 33.75 | 28152594 | |
72 | Phosphorylation | DREHLLSYLEKEALE CHHHHHHHHHHHHHH | 20.89 | 25394399 | |
75 | Ubiquitination | HLLSYLEKEALEHKD HHHHHHHHHHHHCCC | 45.77 | 29967540 | |
75 | 2-Hydroxyisobutyrylation | HLLSYLEKEALEHKD HHHHHHHHHHHHCCC | 45.77 | - | |
81 | Ubiquitination | EKEALEHKDREDYVP HHHHHHCCCHHHCCC | 49.45 | 33845483 | |
86 | Phosphorylation | EHKDREDYVPYTGEK HCCCHHHCCCCCCCC | 9.89 | 28796482 | |
89 | Phosphorylation | DREDYVPYTGEKKGK CHHHCCCCCCCCCCE | 19.82 | 28796482 | |
90 | Phosphorylation | REDYVPYTGEKKGKI HHHCCCCCCCCCCEE | 32.56 | 28555341 | |
93 | 2-Hydroxyisobutyrylation | YVPYTGEKKGKIFIP CCCCCCCCCCEEEEC | 69.07 | - | |
93 | Acetylation | YVPYTGEKKGKIFIP CCCCCCCCCCEEEEC | 69.07 | 25953088 | |
93 | Ubiquitination | YVPYTGEKKGKIFIP CCCCCCCCCCEEEEC | 69.07 | 33845483 | |
96 | Ubiquitination | YTGEKKGKIFIPKQK CCCCCCCEEEECCCC | 43.24 | 33845483 | |
96 | Sumoylation | YTGEKKGKIFIPKQK CCCCCCCEEEECCCC | 43.24 | - | |
96 | Sumoylation | YTGEKKGKIFIPKQK CCCCCCCEEEECCCC | 43.24 | - | |
101 | Ubiquitination | KGKIFIPKQKPVQTF CCEEEECCCCCCCCC | 67.16 | 33845483 | |
103 | Ubiquitination | KIFIPKQKPVQTFTE EEEECCCCCCCCCCH | 53.97 | 27667366 | |
124 | Phosphorylation | PELEEALTSASDTEL HHHHHHHHCCCHHHH | 29.33 | 25159151 | |
125 | Phosphorylation | ELEEALTSASDTELC HHHHHHHCCCHHHHH | 26.99 | 25159151 | |
127 | Phosphorylation | EEALTSASDTELCDL HHHHHCCCHHHHHHH | 44.85 | 28464451 | |
129 | Phosphorylation | ALTSASDTELCDLAA HHHCCCHHHHHHHHH | 28.50 | 26657352 | |
145 | Phosphorylation | LGMHNLITNTKFCNI HCHHHHHCCCCCCHH | 39.75 | 26552605 | |
147 | Phosphorylation | MHNLITNTKFCNIMG HHHHHCCCCCCHHCC | 19.49 | 26552605 | |
155 | Phosphorylation | KFCNIMGSSNGVDQE CCCHHCCCCCCCCHH | 11.84 | 23401153 | |
156 | Phosphorylation | FCNIMGSSNGVDQEH CCHHCCCCCCCCHHH | 31.69 | 30108239 | |
165 | Phosphorylation | GVDQEHFSNVVKGEK CCCHHHHHHCCCCCE | 30.53 | 26552605 | |
169 | Sumoylation | EHFSNVVKGEKILPV HHHHHCCCCCEEEEC | 58.00 | - | |
169 | Acetylation | EHFSNVVKGEKILPV HHHHHCCCCCEEEEC | 58.00 | 25953088 | |
169 | Ubiquitination | EHFSNVVKGEKILPV HHHHHCCCCCEEEEC | 58.00 | 32015554 | |
172 | Ubiquitination | SNVVKGEKILPVFDE HHCCCCCEEEECCCC | 59.20 | 22817900 | |
172 | Acetylation | SNVVKGEKILPVFDE HHCCCCCEEEECCCC | 59.20 | 25953088 | |
191 | Ubiquitination | TNVEESLKRTKENDA CCHHHHHHHHHCCCC | 68.26 | 32015554 | |
191 | 2-Hydroxyisobutyrylation | TNVEESLKRTKENDA CCHHHHHHHHHCCCC | 68.26 | - | |
194 | Ubiquitination | EESLKRTKENDAHLV HHHHHHHHCCCCEEE | 59.56 | 29967540 | |
209 | Sumoylation | EVNLNNIKNIPIPTL EEECCCCCCCCCCCH | 51.45 | - | |
209 | Ubiquitination | EVNLNNIKNIPIPTL EEECCCCCCCCCCCH | 51.45 | 32015554 | |
217 | Ubiquitination | NIPIPTLKDFAKALE CCCCCCHHHHHHHHH | 53.96 | 33845483 | |
221 | Acetylation | PTLKDFAKALETNTH CCHHHHHHHHHCCCC | 54.20 | 26051181 | |
221 | Ubiquitination | PTLKDFAKALETNTH CCHHHHHHHHHCCCC | 54.20 | 33845483 | |
230 | Acetylation | LETNTHVKCFSLAAT HHCCCCCEEEEHHHH | 23.20 | 26051181 | |
230 | Ubiquitination | LETNTHVKCFSLAAT HHCCCCCEEEEHHHH | 23.20 | 29967540 | |
252 | Ubiquitination | TAFAEMLKVNKTLKS HHHHHHHHHCHHHHH | 42.31 | 29967540 | |
289 | Ubiquitination | NETLAELKIDNQRQQ CCCHHEEECHHHHHH | 39.25 | 24816145 | |
294 | Methylation | ELKIDNQRQQLGTAV EEECHHHHHHHHHHH | 32.25 | 24377539 | |
294 | Dimethylation | ELKIDNQRQQLGTAV EEECHHHHHHHHHHH | 32.25 | - | |
307 | Ubiquitination | AVELEMAKMLEENTN HHHHHHHHHHHHHCC | 42.58 | 25015289 | |
308 | Sulfoxidation | VELEMAKMLEENTNI HHHHHHHHHHHHCCH | 4.06 | 30846556 | |
313 | Phosphorylation | AKMLEENTNILKFGY HHHHHHHCCHHHHCC | 27.24 | 28258704 | |
317 | Ubiquitination | EENTNILKFGYQFTQ HHHCCHHHHCCCCCC | 32.71 | 25015289 | |
317 | Sumoylation | EENTNILKFGYQFTQ HHHCCHHHHCCCCCC | 32.71 | - | |
317 | Acetylation | EENTNILKFGYQFTQ HHHCCHHHHCCCCCC | 32.71 | 26051181 | |
320 | Phosphorylation | TNILKFGYQFTQQGP CCHHHHCCCCCCCCC | 12.00 | 28152594 | |
337 | Acetylation | RAANAITKNNDLVRK HHHHHHHCCCHHHHH | 47.87 | 26051181 | |
337 | Ubiquitination | RAANAITKNNDLVRK HHHHHHHCCCHHHHH | 47.87 | 24816145 | |
344 | Ubiquitination | KNNDLVRKRRVEGDH CCCHHHHHHCCCCCC | 36.76 | 29967540 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TMOD3_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TMOD3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TMOD3_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25, AND MASSSPECTROMETRY. |